Challenges for management of immune thrombocytopenia during COVID-19 pandemic.,Journal of Medical Virology

当前位置： X-MOL 学术 › J. Med. Virol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Challenges for management of immune thrombocytopenia during COVID-19 pandemic.
Journal of Medical Virology ( IF 12.7 ) Pub Date : 2020-07-03 , DOI: 10.1002/jmv.26251
Kamal Kant Sahu ₁ , Ahmad Daniyal Siddiqui ₁ , Nima Rezaei _{2,

3,

4} , Jan Cerny ₅

Affiliation

It is almost 6 months since novel coronavirus disease 2019 (COVID‐19) started as a local outbreak in Wuhan, China1 For hematologists and patients suffering from hematological disorders, the COVID‐19 pandemic has brought challenges with regard to the diagnosis, treatment, follow‐up, office visits, and so on.2, 3 We hereby discuss the current challenges for management of immune thrombocytopenia (ITP) during COVID‐19 pandemic, based on our practical experience and interim expert recommendations suggested by the hematology societies.

更新日期：2020-07-03

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>